What are the management strategies for septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Septic Shock

The management of septic shock requires immediate administration of broad-spectrum antibiotics within 1 hour of recognition, rapid fluid resuscitation with at least 30 mL/kg of crystalloids in the first 3 hours, and initiation of norepinephrine as the first-choice vasopressor targeting a mean arterial pressure (MAP) of 65 mmHg. 1

Initial Resuscitation

Fluid Management

  • Administer at least 30 mL/kg of crystalloids IV within the first 3 hours 1
  • Use balanced crystalloids instead of 0.9% saline to reduce adverse renal events 1
  • Continue fluid challenges (20 mL/kg boluses) as long as hemodynamic parameters improve 1
  • Monitor for signs of fluid overload after initial resuscitation 1
  • Evaluate response to fluid administration after each bolus by assessing:
    • Reversal of hypotension
    • Improved urinary output (>0.5 mL/kg/hour)
    • Normalization of capillary refill
    • Decrease in serum lactate 1

Vasopressor Support

  • Initiate vasopressors if hypotension persists despite adequate fluid resuscitation 1
  • Norepinephrine is the first-choice vasopressor (grade 1B recommendation) 2, 1
  • Target MAP ≥65 mmHg 2, 1
  • If additional vasopressor support is needed:
    1. Add vasopressin (0.03 units/minute) to raise MAP or decrease norepinephrine dosage 2, 1
    2. Consider epinephrine as an additional agent or substitute for norepinephrine 2, 1
    3. Consider dopamine only in highly selected patients with low risk of tachyarrhythmias or bradycardia 2
    4. Phenylephrine should be reserved for specific situations (e.g., norepinephrine-associated arrhythmias) 2
  • Place arterial catheter as soon as practical for continuous blood pressure monitoring 1

Administration of Vasopressors

  • Norepinephrine should be diluted in 5% dextrose or 5% dextrose and sodium chloride solutions 3
  • Standard dilution: 4 mg in 1,000 mL (4 mcg/mL) 3
  • Initial dose: 2-3 mL/minute (8-12 mcg/minute) 3
  • Average maintenance dose: 0.5-1 mL/minute (2-4 mcg/minute) 3
  • Titrate according to patient response 3
  • Administer through a large vein, preferably with central venous access 3
  • If central access is unavailable, peripheral administration through a 20-gauge or larger IV is acceptable for short-term use 4

Antimicrobial Therapy

  • Administer IV antimicrobials within one hour of septic shock recognition 1, 4
  • Obtain blood cultures before starting antibiotics (but do not delay administration) 1
  • Use empiric broad-spectrum therapy covering all likely pathogens 1
  • For septic shock, use combination therapy with at least two antibiotics of different classes 1
  • Narrow antimicrobial therapy once pathogen identification and sensitivities are established 1
  • De-escalate combination therapy within the first few days in response to clinical improvement 1
  • Typical treatment duration: 7-10 days for most serious infections 1
  • Delays in appropriate antibiotic therapy beyond 4.5 hours significantly increase mortality 5

Source Control

  • Identify the specific anatomic diagnosis of infection requiring source control as rapidly as possible 1
  • Implement source control intervention within 12 hours of diagnosis 1
  • Promptly remove intravascular access devices that are possible sources of sepsis 1
  • Evaluate for and reverse pneumothorax, pericardial tamponade, or endocrine emergencies in refractory shock 2

Adjunctive Therapies

Corticosteroid Therapy

  • Consider IV hydrocortisone (200 mg/day) only if adequate fluid resuscitation and vasopressor therapy cannot restore hemodynamic stability 1
  • No need for ACTH stimulation test to identify patients who should receive hydrocortisone 1
  • Taper hydrocortisone when vasopressors are no longer required 1
  • Do not use corticosteroids for sepsis in the absence of shock 1

Nutrition and Blood Glucose Control

  • Initiate early enteral nutrition rather than parenteral nutrition 1
  • Provide adequate nutritional support (20-30 kcal/kg/day) 1
  • Target blood glucose ≤180 mg/dL 1
  • Monitor blood glucose every 1-2 hours until stable, then every 4 hours 1

Monitoring and Perfusion Targets

  • Target MAP ≥65 mmHg 2, 1
  • Monitor additional perfusion markers:
    • Urine output (>0.5 mL/kg/hour)
    • Capillary refill
    • Mental status
    • Lactate clearance 1
  • During resuscitation of low ScvO2 shock (<70%), target hemoglobin levels of 10 g/dL 1
  • After stabilization, a lower hemoglobin target of <7.0 g/dL is reasonable 1

Special Considerations

  • Individualize MAP targets: Patients with pre-existing hypertension may require higher MAP targets 2
  • Fluid responsiveness assessment: Use dynamic variables when possible to guide further fluid administration after initial resuscitation 6
  • Vasopressor weaning: Reduce vasopressors gradually to avoid abrupt withdrawal 3
  • Extracorporeal membrane oxygenation (ECMO): Consider for refractory septic shock 2

Pitfalls to Avoid

  1. Delaying antibiotics: Mortality increases significantly with each hour of delay in appropriate antibiotic administration 5, 7
  2. Inadequate fluid resuscitation: Insufficient initial fluid resuscitation is associated with increased vasopressor days and mortality 5
  3. Inappropriate antibiotic dose reduction: Reducing antibiotic doses (e.g., piperacillin-tazobactam) in early septic shock is associated with worse outcomes 7
  4. Overreliance on fixed protocols: Recent evidence suggests that protocolized care offers little advantage over individualized management guided by clinical assessment 8
  5. Failure to identify and control the source: Delays in source control are associated with increased mortality 1
  6. Overlooking occult blood volume depletion: Persistent hypotension despite high vasopressor doses should prompt reassessment for ongoing hypovolemia 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.